-
Mashup Score: 1
Background Elevated heart rate (HR) predicts cardiovascular disease and mortality, but there are no established normal limits for ambulatory HR. We used data from the Swedish CArdioPulmonary Imaging Study to determine reference ranges for ambulatory HR in a middle-aged population. We also studied clinical correlates of ambulatory HR. Methods A 24-hour ECG was registered in 5809 atrial fibrillation-free individuals, aged 50–65 years. A healthy subset (n=3942) was used to establish reference values (excluding persons with beta-blockers, cardiovascular disease, hypertension, heart failure, anaemia, diabetes, sleep apnoea or chronic obstructive pulmonary disease). Minimum HR was defined as the lowest 1-minute HR. Reference ranges are reported as means±SDs and 2.5th–97.5th percentiles. Clinical correlates of ambulatory HR were analysed with multivariable linear regression. Results The average mean and minimum HRs were 73±9 and 48±7 beats per minute (bpm) in men and 76±8 and 51±7 bpm in wome
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23
Advances in Therapy – Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden and is the third leading cause of death worldwide. A high proportion of patients with…
Source: link.springer.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23MACE in COPD: addressing cardiopulmonary risk - 9 day(s) ago
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease are both major global public health burdens, with a burden of 74·4 million and 393 million disability-adjusted life-years, respectively, in 2019.1,2 Given shared exposures and risk factors (eg, smoking, socioeconomic deprivation, diabetes, hypertension, low levels of exercise, and dyslipidaemia), it is not surprising that many people living with COPD have cardiovascular disease. Patients with COPD are two to five times more likely to develop cardiovascular disease compared with the general population.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23
Advances in Therapy – Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden and is the third leading cause of death worldwide. A high proportion of patients with…
Source: link.springer.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 29Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation - Full Text View - ClinicalTrials.gov - 10 day(s) ago
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study - 11 day(s) ago
AbstractBackground. Myocardial injury is prevalent among patients hospitalized for COVID-19. However, the role of COVID-19 vaccines in modifying the risk of myo
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23
Advances in Therapy – Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden and is the third leading cause of death worldwide. A high proportion of patients with…
Source: link.springer.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Mohit Bhutani - Directory@UAlberta.ca - 14 day(s) ago
University of Alberta: Directory@UAlberta.ca
Source: apps.ualberta.caCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Delineation of Acute Coronary Syndromes: The Acute Total Occlusion versus ST segment paradigm - 16 day(s) ago
Kush P Patel, Andreas Baumbach; Delineation of Acute Coronary Syndromes: The Acute Total Occlusion versus ST segment paradigm, European Heart Journal – Qua
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer - 16 day(s) ago
Objectives Long-term follow-up of patients treated with trastuzumab largely focuses on those with reduced left ventricular ejection fraction (LVEF) on treatment completion. This study sought to evaluate the prevalence of cardiovascular risk factors, overt cardiovascular disease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously. Methods Participants with human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab±anthracycline ≥5 years previously were identified from a clinical database. All participants had normal LVEF prior to, and on completion of, treatment. Participants underwent clinical cardiovascular evaluation, ECG, cardiac biomarker evaluation and CMR. Left ventricular systolic dysfunction (LVSD) was defined as LVEF <50%. Results Forty participants were recruited between 15 March 2021 and 19 July 2022. Median time
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
🤔. Yep, ambulatory heart rate varies widely, & is not really explained by clinical correlates. Reference ranges for ambulatory heart rate measurements in a middle-aged population @Heart_BMJ https://t.co/MDCLM3AW6Q